This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe
1-3 December 2025
Mercure Hotel MOABerlin, Germany

Hiroyuki Usuda
Scouting & Transaction Lead, Business Development at Astellas Pharma Europe Ltd
Speaker

Profile

Hiro Usuda is Scouting & Transaction Lead, Business Development at Astellas. He moved to Cambridge, UK, in 2021 when Astellas launched a BD office there. He is responsible for introducing European technologies and assets to global Astellas, communicating with external partners, and creating new collaborations, licensing, M&A, and investments (including those in Cell and gene therapy). Hiro started his career at Astellas as a medicinal chemist, developing candidate drugs in immunology and oncology drug candidates as a bench chemist and group leader.

Agenda Sessions

  • Chairperson's Opening Remarks

    11:10
  • Panel Discussion: Strategies for Scaling Up, Accelerating and Commercialising Gene Therapy Manufacturing

    16:40
  • Round Table Discussions - Table 1: AI Revolution in CGT Manufacturing, Table 2: From Rare Diseases to Mainstream Markets

    13:00